Belgium· BE-AMP-SAM208625-00
Ultraproct 500 mg - 94,5 mg - 91,8 mg
A agents for treatment of hemorrhoids and anal fissures for topical use product containing cinchocaine hydrochloride, registered in Belgium by Bayer.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Cinchocaine Hydrochloride
- Manufacturer
- Bayer
- Country
- Belgium (BE)
- ATC code
- C05A
- ATC class
- AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 1
- be_apb0094052
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Cinchocaine hydrochloride in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesCVS Topical Analgesic HemorrhoidalCVS PHARMACY,INC
- GermanyCincainSmartpractice Europe Gmbh
- United KingdomNupercainal 1.1% ointmentBoston Healthcare Ltd
- FinlandOrodropsOrion Corporation
Authorised across Europe · EMA
The same active substance is authorised in 5 EEA countries. Names it is sold under:
- Germany · Cincain, Doloposterine N Salbe
- Finland · Orodrops
- Greece · Otaset
- Italy · Cincocaina Cloridrato Allergeaze Smartpractice Europe
- Portugal · Nupercainal
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/3954b1f4-1629-4003-8bb5-9b47564aa6ee GET /v1/drugs/3954b1f4-1629-4003-8bb5-9b47564aa6ee?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Ointment",
"source": "afmps",
"status": "REVOKED",
"name_en": "Ultraproct 500 mg - 94,5 mg - 91,8 mg",
"name_fr": "Ultraproct 500 mg - 94,5 mg - 91,8 mg",
"name_nl": "Ultraproct 500 mg - 94,5 mg - 91,8 mg",
"amp_code": "SAM208625-00",
"strengths": [
"5.0000",
"91.8000",
"94.5000"
],
"pack_count": 1,
"substances": [
"Cinchocaine Hydrochloride",
"Fluocortolone Pivalate",
"Fluocortolone Caproate"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use",
"authorisation_numbers": [
"BE208625"
]
}See everything about cinchocaine hydrochloride.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.